PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:21 AM ET

Sponsor Check › Person

PC
No photo found yet (own website and image search run after this page is viewed)

Peter R. Culpepper

Named as an officer, director or promoter on SEC Form D filings · TN · Jun 30, 2009 → Oct 15, 2014

1deal (issuers)
$7.94Mreported sold
90investors
14Form D filings
2009–2014years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:17 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Peter R. Culpepper is listed as an executive officer and promoter on 14 SEC Form D filings by 1 issuer between Jun 2009 and Oct 2014: PROVECTUS BIOPHARMACEUTICALS, INC. (Knoxville, TN — pharmaceuticals — 2009–2014; $7.94M reported sold to 90 investors).

What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.

Listed alongside Kelly M. McMasters (14 shared filings), Eric A. Wachter (13 shared filings), Timothy C. Scott (13 shared filings), Alfred E. Smith IV (7 shared filings), Craig H. Dees (7 shared filings) and 5 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Peter. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 SEC release listed in Key records below.

What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 14 public filings for Peter R. Culpepper and found 12 differences, 5 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Peter R. Culpepper has not run yet — it is joining a line of 13,889 names; searches run around the clock at the hosts' allowed rate. Searched so far: 28 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:17 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

1 SEC release

Peter R. Culpepper, CPA Administrative proceeding
SEC · Dec 12, 2017 · Parties as named in the release: Peter R. Culpepper, CPA Read the release ↗
same full name in the release title; the person's filing state is named in the release; Form D issuer PROVECTUS BIOPHARMACEUTICALS, INC. named in the release
What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Peter R. Culpepper..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:17 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

12 differences found between the filings for Peter R. Culpepper — 5 worth asking about (compared 14 filings on Oct 24, 2026)

Worth asking · Mar 26, 2010 – Apr 6, 2010

Amount sold went down between filings — PROVECTUS BIOPHARMACEUTICALS, INC.

The Mar 26, 2010 filing says $7,613,327 sold; the Apr 6, 2010 Form D says $1,271,900 sold — $6,341,427 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D/A (earlier) · Mar 26, 2010 ↗Form D (later) · Apr 6, 2010 ↗PROVECTUS BIOPHARMACEUTICALS, INC. — PartnerFacts page ↗
Sources
Worth asking · Mar 24, 2010 – Mar 26, 2010

Amount sold went down between filings — PROVECTUS BIOPHARMACEUTICALS, INC.

The Mar 24, 2010 filing says $7,937,499 sold; the Mar 26, 2010 Form D/A says $7,613,327 sold — $324,172 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Mar 24, 2010 ↗Form D/A (later) · Mar 26, 2010 ↗PROVECTUS BIOPHARMACEUTICALS, INC. — PartnerFacts page ↗
Sources
Worth asking · Mar 26, 2010 – Apr 6, 2010

Investor count went down between filings — PROVECTUS BIOPHARMACEUTICALS, INC.

The Mar 26, 2010 filing reports 90 investors; the Apr 6, 2010 Form D reports 14 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D/A (earlier) · Mar 26, 2010 ↗Form D (later) · Apr 6, 2010 ↗PROVECTUS BIOPHARMACEUTICALS, INC. — PartnerFacts page ↗
Sources
Worth asking · Aug 7, 2009 – Mar 24, 2010

Investor count went down between filings — PROVECTUS BIOPHARMACEUTICALS, INC.

The Aug 7, 2009 filing reports 90 investors; the Mar 24, 2010 Form D reports 36 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D/A (earlier) · Aug 7, 2009 ↗Form D (later) · Mar 24, 2010 ↗PROVECTUS BIOPHARMACEUTICALS, INC. — PartnerFacts page ↗
Sources
Worth asking · May 26, 2009 – Sep 26, 2013

6 Form Ds were filed more than 15 days after the first sale

Form D filed 198 days after the first sale — PROVECTUS BIOPHARMACEUTICALS, INC. · Form D filed 128 days after the first sale — PROVECTUS BIOPHARMACEUTICALS, INC. · Form D filed 175 days after the first sale — PROVECTUS BIOPHARMACEUTICALS, INC. · Form D filed 17 days after the first sale — PROVECTUS BIOPHARMACEUTICALS, INC. · Form D filed 18 days after the first sale — PROVECTUS BIOPHARMACEUTICALS, INC. · and 1 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Sep 26, 2013 ↗PROVECTUS BIOPHARMACEUTICALS, INC. — PartnerFacts page ↗Form D · Aug 3, 2012 ↗Form D · Mar 22, 2012 ↗
Sources
Note · Mar 8, 2013 – Sep 26, 2013

Peter R. Culpepper's role changed at PROVECTUS BIOPHARMACEUTICALS, INC.: executive officer, promoter → executive officer

The Mar 8, 2013 filing lists Peter R. Culpepper as executive officer, promoter; the Sep 26, 2013 Form D lists executive officer.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Mar 8, 2013 ↗Form D · Sep 26, 2013 ↗Peter R. Culpepper — PartnerFacts page ↗PROVECTUS BIOPHARMACEUTICALS, INC. — PartnerFacts page ↗
Sources
Note · Nov 19, 2012 – Mar 8, 2013

Peter R. Culpepper's role changed at PROVECTUS BIOPHARMACEUTICALS, INC.: executive officer → executive officer, promoter

The Nov 19, 2012 filing lists Peter R. Culpepper as executive officer; the Mar 8, 2013 Form D lists executive officer, promoter.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Nov 19, 2012 ↗Form D · Mar 8, 2013 ↗Peter R. Culpepper — PartnerFacts page ↗PROVECTUS BIOPHARMACEUTICALS, INC. — PartnerFacts page ↗
Sources
Note · Jun 30, 2009 – Apr 6, 2010

4 offerings changed their target amount between filings

Offering amount lowered between filings — PROVECTUS BIOPHARMACEUTICALS, INC. · Offering amount changed between filings — PROVECTUS BIOPHARMACEUTICALS, INC. · Offering amount changed between filings — PROVECTUS BIOPHARMACEUTICALS, INC. · Offering amount changed between filings — PROVECTUS BIOPHARMACEUTICALS, INC.

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D/A (earlier) · Mar 26, 2010 ↗Form D (later) · Apr 6, 2010 ↗PROVECTUS BIOPHARMACEUTICALS, INC. — PartnerFacts page ↗Form D (earlier) · Mar 24, 2010 ↗
Sources
Note · Apr 29, 2010 – Apr 17, 2014

7 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — PROVECTUS BIOPHARMACEUTICALS, INC. (latest filing Apr 17, 2014) · No amendment in the last 12 months on an offering that may still be open — PROVECTUS BIOPHARMACEUTICALS, INC. (latest filing Sep 26, 2013) · No amendment in the last 12 months on an offering that may still be open — PROVECTUS BIOPHARMACEUTICALS, INC. (latest filing Nov 19, 2012) · No amendment in the last 12 months on an offering that may still be open — PROVECTUS BIOPHARMACEUTICALS, INC. (latest filing Aug 3, 2012) · No amendment in the last 12 months on an offering that may still be open — PROVECTUS BIOPHARMACEUTICALS, INC. (latest filing Mar 22, 2012) · and 2 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Apr 17, 2014 ↗PROVECTUS BIOPHARMACEUTICALS, INC. — PartnerFacts page ↗Form D · Sep 26, 2013 ↗Form D · Nov 19, 2012 ↗
Sources
Note · Jun 30, 2009 – Apr 17, 2014

Reported revenue range changed between filings — PROVECTUS BIOPHARMACEUTICALS, INC.

"No Revenues" (Jun 30, 2009); then "Decline to Disclose" (Apr 17, 2014).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Jun 30, 2009 ↗Form D · Apr 17, 2014 ↗PROVECTUS BIOPHARMACEUTICALS, INC. — PartnerFacts page ↗
Sources
Note · Mar 24, 2010 – Mar 26, 2010

Minimum investment changed between filings — PROVECTUS BIOPHARMACEUTICALS, INC.

The Mar 24, 2010 filing lists a minimum of $25,000; the Mar 26, 2010 Form D/A lists $0.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Mar 24, 2010 ↗Form D/A (later) · Mar 26, 2010 ↗PROVECTUS BIOPHARMACEUTICALS, INC. — PartnerFacts page ↗
Sources
Note · Aug 7, 2009 – Mar 24, 2010

Minimum investment changed between filings — PROVECTUS BIOPHARMACEUTICALS, INC.

The Aug 7, 2009 filing lists a minimum of $0; the Mar 24, 2010 Form D lists $25,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D/A (earlier) · Aug 7, 2009 ↗Form D (later) · Mar 24, 2010 ↗PROVECTUS BIOPHARMACEUTICALS, INC. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

5 of 10 offerings report sales commissions totalling $2,616,776; 0 report finder's fees; 1 reports proceeds to related persons totalling $1,000,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Oct 15, 2014 D
PROVECTUS BIOPHARMACEUTICALS, INC.
File 021-226419
$0$0$0Network 1 Financial Securities, Inc. BrokerCheck CRD 13577 ↗EDGAR ↗
Apr 17, 2014 D
PROVECTUS BIOPHARMACEUTICALS, INC.
File 021-215835
$334,587 (est.)$0$0Network 1 Financial Securities, Inc. BrokerCheck CRD 13577 ↗EDGAR ↗
Sep 26, 2013 D
PROVECTUS BIOPHARMACEUTICALS, INC.
File 021-203611
$1,600,000 (est.)$0$1,000,000 (est.)Network 1 Financial Securities, Inc. BrokerCheck CRD 13577 ↗
Maxim Group LLC BrokerCheck CRD 1207087 ↗		EDGAR ↗
Mar 8, 2013 D
PROVECTUS BIOPHARMACEUTICALS, INC.
File 021-192992
$0$0$0None listed on this filingEDGAR ↗
Nov 19, 2012 D
PROVECTUS BIOPHARMACEUTICALS, INC.
File 021-187245
$500,000 (est.)$0$0Network 1 Financial Securities, Inc. BrokerCheck CRD 13577 ↗EDGAR ↗
Aug 3, 2012 D
PROVECTUS BIOPHARMACEUTICALS, INC.
File 021-182219
$0$0$0Network 1 Financial Securities, Inc. BrokerCheck CRD 13577 ↗EDGAR ↗
Mar 22, 2012 D
PROVECTUS BIOPHARMACEUTICALS, INC.
File 021-175356
$54,999$0$0Network 1 Financial Securities, Inc. BrokerCheck CRD 13577 ↗EDGAR ↗
May 5, 2011 D
PROVECTUS BIOPHARMACEUTICALS, INC.
File 021-159343
$0$0$0Network 1 Financial Securities, Inc. BrokerCheck CRD 13577 ↗EDGAR ↗
May 13, 2010 D
PROVECTUS BIOPHARMACEUTICALS, INC.
File 021-141963
$0 (est.)$0$0None listed on this filingEDGAR ↗
Apr 6, 2010 D
PROVECTUS BIOPHARMACEUTICALS, INC.
File 021-13551-D
$127,190 (est.)$0$0Asher Wolmark BrokerCheck CRD 2064857 ↗
via Brewer Financial Services, LLC (CRD 132558 ↗)

William David Vellon BrokerCheck CRD 1954258 ↗
via Brewer Financial Services, LLC (CRD 132558 ↗)
EDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 1

Every issuer that named Peter R. Culpepper on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

PB
Pharmaceuticals

PROVECTUS BIOPHARMACEUTICALS, INC.

Knoxville, TN · Jun 30, 2009 → Oct 15, 2014 · 14 filings
  • Oct 15, 2014 · D · $0 sold of $15,000,000 · 0 investors · min. No minimum reported · role: Executive Officer (CFO, COO, CAO) EDGAR ↗
  • Apr 17, 2014 · D · $3,373,250 sold of $5,000,000 · 17 investors · min. No minimum reported · role: Executive Officer (CFO, COO, CAO) EDGAR ↗
  • Sep 26, 2013 · D · $7,798,037 sold of $16,000,000 · 67 investors · min. $25,000 · role: Executive Officer (CFO, COO, CAO) EDGAR ↗
  • Mar 8, 2013 · D · $2,550,000 sold of $2,550,000 · 3 investors · min. No minimum reported · role: Promoter, Executive Officer (CFO, COO, CAO) EDGAR ↗
  • Nov 19, 2012 · D · $2,034,675 sold of $5,000,000 · 5 investors · min. No minimum reported · role: Executive Officer (CFO, COO, CAO) EDGAR ↗
  • Aug 3, 2012 · D · $2,077,796 sold of $4,999,999 · 16 investors · min. No minimum reported · role: Executive Officer (CFO, COO, CAO) EDGAR ↗
  • Mar 22, 2012 · D · $499,999 sold of $2,499,999 · 6 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • May 5, 2011 · D · $4,615,300 sold of $5,000,000 · 26 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • May 13, 2010 · D · $200,000 sold of $1,000,000 · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Apr 6, 2010 · D · $1,271,900 sold of $1,271,900 · 14 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Mar 26, 2010 · D/A · $7,613,327 sold of $10,363,327 · 90 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Mar 24, 2010 · D · $7,937,499 sold of $10,000,000 · 36 investors · min. $25,000 · role: Executive Officer EDGAR ↗
  • Aug 7, 2009 · D/A · $4,507,176 sold of $4,507,176 · 90 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Jun 30, 2009 · D · $2,712,000 sold of $3,500,000 · 47 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $7.94M from 90 investors (53% of the $15M target) as of the latest filing. Peter is listed as executive officer, promoter on 14 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Peter 10

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

KM
No photo found yet (own website and image search run after this page is viewed)
Person

Kelly M. McMasters

Director · 14 shared filings (1 issuer)

Listed on the same filings as Peter R. Culpepper. Their page shows their other deals.

TS
No photo found yet (own website and image search run after this page is viewed)
Person

Timothy C. Scott

Executive Officer, Director · 13 shared filings (1 issuer)

Listed on the same filings as Peter R. Culpepper. Their page shows their other deals.

EW
No photo found yet (own website and image search run after this page is viewed)
Person

Eric A. Wachter

Executive Officer, Director · 13 shared filings (1 issuer)

Listed on the same filings as Peter R. Culpepper. Their page shows their other deals.

SF
No photo found yet (own website and image search run after this page is viewed)
Person

Stuart Fuchs

Director · 7 shared filings (1 issuer)

Listed on the same filings as Peter R. Culpepper. Their page shows their other deals.

HD
No photo found yet (own website and image search run after this page is viewed)
Person

H. Craig Dees

Executive Officer, Director · 7 shared filings (1 issuer)

Listed on the same filings as Peter R. Culpepper. Their page shows their other deals.

CD
No photo found yet (own website and image search run after this page is viewed)
Person

Craig H. Dees

Executive Officer, Director · 7 shared filings (1 issuer)

Listed on the same filings as Peter R. Culpepper. Their page shows their other deals.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Alfred E. Smith IV

Director, Executive Officer · 7 shared filings (1 issuer)

Listed on the same filings as Peter R. Culpepper. Their page shows their other deals.

JK
No photo found yet (own website and image search run after this page is viewed)
Person

Jan Koe

Director · 6 shared filings (1 issuer)

Listed on the same filings as Peter R. Culpepper. Their page shows their other deals.

EW
No photo found yet (own website and image search run after this page is viewed)
Person

Eris A. Wachter

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Peter R. Culpepper. Their page shows their other deals.

TS
No photo found yet (own website and image search run after this page is viewed)
Person

Tim Scott

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Peter R. Culpepper. Their page shows their other deals.

The team behind the deals

Same business address

1 other issuer file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 1 issuer this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Peter R. Culpepper by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 1 issuer this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Peter R. Culpepper is listed on: none on file. No website or social profile named in PROVECTUS BIOPHARMACEUTICALS, INC.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #95,636 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Knoxville, TN). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Davidson County TN Circuit Court Clerk case search ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Tennessee Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Peter R. Culpepper appears on a new Form D, or when a court case or SEC action is matched to them. See plans →